¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"induction shock"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • self induction
    ÀÚ°¡À¯µµ
  • sex induction
    ¼ºÀÎÀÚÀ¯µµ
  • slow induction
    ´À¸°¸¶ÃëÀ¯µµ
  • zygotic induction
    Á¢ÇÕÀÚÀ¯µµ
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼îÅ©
  • circulatory shock
    ¼øÈ¯¼îÅ©
  • cold shock
    ÇÑ·©¼îÅ©
  • counter shock
    ¸ÂÃæ°Ý, ¿ªÃæ°Ý
  • culture shock
    ¹®È­Ãæ°Ý
  • cardiogenic shock
    ½ÉÀ强¼îÅ©
  • diastolic shock
    È®Àå±â¼îÅ©
  • extracorporeal shock wave lithotripsy
    ü¿ÜÃæ°ÝÆÄ¼â¼®(¼ú), ¸ö¹ÛÃæ°ÝÆÄµ¹±þ¼ú
  • electric shock
    Àü±âÃæ°Ý
  • electric shock therapy
    Àü±âÃæ°Ý¿ä¹ý
  • endotoxin shock
    ³»µ¶¼Ò¼îÅ©
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • rapid-sequence induction
    ºü¸¥¿¬¼Ó¸¶ÃëÀ¯µµ
  • self induction
    ÀÚ±âÀ¯µµ
  • sex induction
    ¼ºÀÎÀÚÀ¯µµ
  • slow induction
    ´À¸°¸¶ÃëÀ¯µµ
  • transfinite induction
    ¹«ÇÑÀ¯µµ
  • zygotic induction
    Á¢ÇÕÀ¯µµ
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼îÅ©, Ãʰú¹Î¹ÝÀÀ¼îÅ©
  • shock absorber
    Ãæ°Ý¿ÏÃæ±â
  • bacterial shock
    ¼¼±Õ¼îÅ©
  • cardiogenic shock
    ½ÉÀ强¼îÅ©, ½ÉÀåÅ¿¼îÅ©
  • circulatory shock
    ¼øÈ¯¼îÅ©
  • cold shock
    ÇÑ·©¼îÅ©
  • convulsive shock therapy
    °æ·ÃÃæ°Ý¿ä¹ý
  • counter shock
    ¸ÂÃæ°Ý
  • culture shock
    ¹®È­Ãæ°Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • positive induction
    ¾ç¼ºµµÃâ<À¯µµ>(åÕàõÓôõó<ë¯Óô>).
  • rapid induction
    ±Þ¼ÓµµÀÔ, ½Å¼Ó¸¶ÃëÀ¯µµ.
  • remission induction therapy
    °üÇØÀ¯µµÄ¡·á(ΰú°ë¯Óôö½èþ).
  • Heat shock protein
    ¿­¼ï´Ü¹éÁú
  • Hypovolemic shock
    Ç÷¾×·®°¨¼Ò(úìäûÕáÊõá´)¼îÅ©
  • Insulin shock
    Àν¶¸°¼ï
  • Irreversible shock
    ºñ°¡¿ªÀû(ުʦæ½îÜ) ¼ï
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã¼º ¼ï, °ú¹Î¼º ¼ï.
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼º ¼ï, °ú¹Î¼º ¼ï.
  • gram negative shock
    ±×·¥À½¼º¼ï.
  • heat shock
    ¿­Ãæ°Ý
  • heat shock protein
    ¿­Ãæ°Ý´Ü¹éÁú
  • heat shock protein
    ¿­Ãæ°Ý ´Ü¹éÁú
  • heat shock protein
    ¿­Ãæ°Ý ´Ü¹é
  • heat shock response
    ¿­Ãæ°Ý¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • induction, tolerance
    °ü¿ëÀ¯¹ß (¸é¿ª)
  • magnetic induction
    ÀÚ±â À¯µµ
  • magnetic induction field
    ÀÚ±â À¯µµ ÀÚÀå
  • mathematical induction
    ¼öÇÐÀû ±Í³³¹ý(Ëà̰ ËøË´ËÀËÑ).
  • nuclear induction
    ÇÙ À¯µµ
  • ovulation induction
    ¹è¶õÀ¯µµ
  • oxytocin induction =OI
    ¿Á½ÃÅä½Å¿¡ ÀÇÇÑ ºÐ¸¸ À¯µµ.
  • parallel induction
    ÆòÇàÀ¯µµ(øÁú¼ë¯Óô).
  • positive induction
    ¾ç¼ºµµÃâ<À¯µµ>(åÕàõÓôõó<ë¯Óô>).
  • rapid induction
    ±Þ¼ÓµµÀÔ, ½Å¼Ó¸¶ÃëÀ¯µµ.
  • remission induction therapy
    °üÇØÀ¯µµÄ¡·á(ΰú°ë¯Óôö½èþ).
  • retinal induction
    ¸Á¸·À¯µµ(¡­ë¯Óô)
  • self induction
    ÀÚ±âÀ¯µµ.
  • sequential induction
    ¼øÂ÷Àû À¯µµ(ËàÌ¤Ëø ËôËÀ).
  • sex induction
    ¼ºÀÎÀÚµµÀÔ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gratuitous induction
    ¹«»ó À¯µµ(ÙíßÁë¯Óô)
  • indirect induction
    °£Á¢À¯µµ(ÊàïÈë¯Óô)
  • induction
    À¯µµ(ë¯Óô)
  • induction effect
    À¯µµÈ¿°ú(ë¯ÓôüùÍý)
  • induction period
    À¯µµ±â°£(ë¯ÓôÑ¢Êà)
  • induction profile
    À¯µµ¾ç»ó(ë¯ÓôåÆßÓ)
  • induction ratio
    À¯µµºñ(ë¯ÓôÝï)
  • morphogenic induction
    ÇüÅÂÇü¼ºÀ¯µµ(û¡÷¾û¡à÷ë¯Óô)
  • multistep induction theory
    ´Ù´Ü°è À¯µµ·Ð(ÒýÓ«Í­ë¯ÓôÖå)
  • persistent induction
    Áö¼Ó À¯µµ(ò¥áÙë¯Óô)
  • phage induction
    ÆäÀÌÁö À¯µµ(ë¯Óô)
  • prophage induction
    ÇÁ·ÎÆäÀÌÁö À¯µµ(ë¯Óô)
  • sequencial induction
    ¼øÂ÷À¯µµ(â÷ó­ë¯Óô)
  • spontaneous induction
    ÀÚ¿¬ À¯µµ(í»æÔë¯Óô)
  • zygotic induction
    Á¢ÇÕÀ¯µµ(ïÈùêë¯Óô)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IOL induction of labor; intraocular lens
IP icterus praecox; imaging plate; immune precipitate; immunoblastic plasma; immunoperoxidase technique...
MI first meiotic metaphase; maturation index; medical illustrator; medical informatics; medical inspect...
RI radiation intensity; radioactive isotope; radioimmunology; recession index; recombinant inbred [stra...
RSI rapid-sequence induction; rapid sequence intubation; repetition strain injury
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HSP 2)/heat shock protein
ESWL 2--extracorporeal shock-wave lithotripsy
CS Cardiogenic shock
CSD Cold shock domain
CSP cold shock protein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pain shock
    µ¿Åë ¼ï
  • physiologic shock absorber
    »ý¸®Àû Ãæ°Ý Èí¼ö´ë
  • post electric shock syndrome
    Àü°Ý ¼ï ÈÄ ÁõÈıº
  • primary shock
    ÀÏÂ÷¼º ¼ï
  • semi-shock
    ¹Ý¼îÅ©
    ´ë»ó ±â±¸°¡ ÀÛ¿ëÇØ, °Ü¿ì ¼îÅ©¸¦ ¸éÇÏ´Â °æ¿ì.
  • shock
    ¼ï
    1. ½Åü ÆòÇüÀÇ °©ÀÛ½º·¯¿î Àå¾Ö. 2. ÁÖ¿ä Àå±â¿¡ ´ëÇÑ Ç÷·ù À¯Áö¸¦ À§ÇÑ ¼øÈ¯°èÀÇ, ±â´É »ó½Ç·Î Ư¡ Áö¿öÁö´Â ½É°¢ÇÑ Ç÷¾× ¼øÈ¯°ú ´ë»çÀÇ ¹æÇØ Á¶°Ç. ÀÌ´Â Ç÷¾×·®ÀÇ ÀúÇÏ·Î ¹ß»ýÇÒ ¼öµµ ÀÖ°í, ½É±â´É ÀúÇÏ È¤Àº ºñÁ¤»óÀûÀÎ vasomotor toneÀ¸·Î ÀÎÇÑ °æ¿ìµµ ÀÖ´Ù. ÀúÇ÷¾Ð, ÇǺÎÀÇ ÇÑ·©, Åë»óÀº ºó¸Æ, Á¾Á¾ ºÒ¾ÈÀ» Ư¡À¸·Î ÇÑ´Ù.
  • shock circuit reaction
    ´Ü¶ô ¹ÝÀÀ
    °¨Á¤Àû Ãæµ¿ÀÌ À̼ºÀÇ ÅëÁ¦¸¦ ¹þ¾î³ª Á÷Á¢À¸·Î Çൿ¿¡ ¿Å°ÜÁö´Â ¹ÝÀÀ.
  • shock kidney
    ¼îÅ©¼º ½Å ±â´É Àå¾Ö
    ¼îÅ©¿¡ ºüÁ® Ç÷¾Ð ÀúÇϰ¡ ±æ°Ô À̾îÁ® ½Å Ç÷·ù·®ÀÌ °¨¼ÒÇÏ¿© »ý±ä ±Þ¼º ½Å ºÎÀü.
  • shock lung
    ¼îÅ© Æó
    ÃâÇ÷¼º ¼îÅ© µî¿¡ ÇÕº´Çϴ ȣÈí ºÎÀü.
  • shock position
    ¼ï À§Ä¡
    ȯÀÚ°¡ ¼îÅ©¸¦ ÀÏÀ¸Ä×À» ¶§ ±× ±¸±Þ üÀ§·Î¼­ ÃëÇØÁö´Â üÀ§.
  • shock shortening heat
    ´ÜÃà ¿­
    ´ÜÃàÇÏ´Â ±æÀÌ¿¡ ºñ·ÊÇØ ºÎÇÏ¿¡ °ü°è¾øÀÌ ¹ß»ýÇÏ´Â ¿­.
  • shock term memory
    ´Ü±â ±â¾ï
  • shock treatment
    ¼ï Ä¡·á
    Ä«¸£µð¾ÆÁ¹ °æ·Ã ¿ä¹ý, Àü±â ¼îÅ© ¿ä¹ý, Àν¶¸° ¼îÅ© ¿ä¹ý µîÀÌ ÀÖ´Ù.
  • shock wave imaging
    Ãæ°ÝÆÄ »ó
  • state of shock
    Ãæ°Ý »óÅÂ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
zygotic induction <cell biology> A lysogenic process in which a prophage is transmitted to a cell that does not have a phage repressor protein.
(09 Oct 1997)
free induction decay In magnetic resonance imaging, the decay curve that is detected by the radiofrequency coil after the application of an excitation pulse, without additional pulses (free).
(05 Mar 2000)
lysogenic induction Induction that occurs when prophage is transferred to a nonlysogenic bacterium by conjugation or by transduction.
(05 Mar 2000)
anaesthetic shock Shock produced by the administration of anaesthetic drug(s), usually in relative overdosage.
(05 Mar 2000)
anaphylactic shock <immunology> A serious, often life-threatening allergic reaction that is characterised by low blood pressure, shock (poor tissue perfusion) and difficulty breathing.
(27 Sep 1997)
anaphylactoid shock A reaction that is similar to anaphylactic shock, but which does not require the incubation period characteristic of induced sensitivity (anaphylaxis); it is unrelated to antigen-antibody reactions.
Synonym: anaphylactoid crisis, pseudoanaphylactic shock.
(05 Mar 2000)
break shock The shock produced by breaking a constant current passing through the body.
(05 Mar 2000)
cardiac shock A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy.
Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully.
(27 Sep 1997)
cardiogenic shock A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy.
Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully.
(27 Sep 1997)
cardiopulmonary obstructive shock <cardiology> This term describes a number of conditions that involve a severe disturbance of the cardiopulmonary circuit resulting in shock (inadequate delivery of oxygen to the tissues).
Examples include: pulmonary embolism, pericardial tamponade, pneumothorax and constrictive pericarditis.
(27 Sep 1997)
vasogenic shock Shock resulting from depressed activity of the higher vasomotor centres in the brain stem and the medulla, producing vasodilation without loss of fluid so that the container is disproportionately large. In oligaemic shock, blood volume is reduced; in both, return of venous blood is inadequate.
(05 Mar 2000)
reversible shock Shock that will respond to treatment and from which recovery is possible.
(05 Mar 2000)
chronic shock The state of peripheral circulatory insufficiency developing in elderly patients with a debilitating disease, e.g., carcinoma; a subnormal blood volume makes the patient susceptible to haemorrhagic shock as a result of even a moderate blood loss such as may occur during an operation.
(05 Mar 2000)
wet shock A severe condition that occurs when the level of blood glucose (sugar) drops quickly. The signs are shaking, sweating, dizziness, double vision, convulsions, and collapse. Insulin shock may occur when an insulin reaction is not treated quickly enough.
See: hypoglycaemia.
(09 Oct 1997)
cultural shock A form of stress associated with the beginning of an individual's assimilation into a new culture vastly different from that in which he or she was raised.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • future shock
    ¹Ì·¡ Ãæ°Ý(±Þ°ÝÇÑ »çȸ º¯È­¿¡ ÀûÀÀÇÏÁö ¸øÇÏ´Â »ç¶÷ÀÇ °í¹Î)
  • insulin shock(coma)
    Àν¶¸°¼îÅ©(Àν¶¸° °úÀ× Åõ¿©·Î ÀϾ´Â ¼îÅ©)
  • reverse culture shock
    ¿ª¹®È­ ¼îÅ©(¿Ü±¹¿¡¼­ ¿À·§µ¿¾È »ýȰÇÑ »ç¶÷ÀÌ °í±¹À¸·Î µ¹¾Æ¿ÔÀ» ¶§ ´À³¢´Â ¼Ò¿Ü°¨)
  • shell shock
    ÀüÀZ Á¤½Å ÀÌ»ó
  • shock
    (¿Á¼ö¼ö,¹Ð µûÀ§ÀÇ)¤°¡¸®;°¡¸®´Ù
  • shock
    Ãæ°Ý;Ãæµ¹;°Ýµ¹;Áøµ¿;(Á¤½ÅÀû)Ÿ°Ý;¼îÅ©;Ãæ°ÝÀ» ÁÖ´Ù;Ãæµ¹ÇÏ´Ù
  • shock
    ÇëŬ¾îÁø ¸Ó¸®;ºÎ½º½ºÇÑ(´õºÎ·èÇÑ)°Í
  • shock absorber
    ¿ÏÃæ±â
  • shock action
    Ãæ°Ý
  • shock dog
    »ð»ì°³
  • shock stall
    Ãæ°ÝÆÄ ½Ç¼Ó
  • shock therapy
    (Á¤½Åº´ÀÇ)Ãæ°Ý(Àü°Ý)¿ä¹ý
  • shock troops
    Ư°ø´ë
  • shock wave
    Ãæ°ÝÆÄ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á